Genetic Variants of DMBT1 and SFTPD and Disease Severity in Paediatric Inflammatory Bowel Disease-A Polish Population-Based Study.
Crohn’s disease
exacerbation
hospitalisation
immunosuppression
polymorphism
relapse
ulcerative colitis
Journal
Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936
Informations de publication
Date de publication:
21 Oct 2021
21 Oct 2021
Historique:
received:
14
09
2021
revised:
08
10
2021
accepted:
09
10
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
28
11
2021
Statut:
epublish
Résumé
Deleted in malignant brain tumours 1 protein (DMBT1) and surfactant protein D (SFTPD) are antimicrobial peptides previously linked to inflammatory bowel disease (IBD) susceptibility. This study attempts to link the most potential IBD-associated polymorphisms in DMBT1 and SFTPD with the disease severity in children. A total of 406 IBD patients (Crohn's disease (CD)
Identifiants
pubmed: 34828659
pii: children8110946
doi: 10.3390/children8110946
pmc: PMC8618964
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : National Science Center
ID : 2017/25/B/NZ5/02783
Références
Gut. 2019 Aug;68(8):1386-1395
pubmed: 31030191
Nutrients. 2020 Sep 17;12(9):
pubmed: 32957486
Inflamm Bowel Dis. 2006 Dec;12(12):1114-21
pubmed: 17119385
Clin Gastroenterol Hepatol. 2009 Sep;7(9):972-980.e2
pubmed: 19422935
Gastroenterology. 2002 Apr;122(4):854-66
pubmed: 11910336
J Immunol. 1997 Dec 1;159(11):5450-6
pubmed: 9548485
J Immunol. 2006 Dec 1;177(11):7551-8
pubmed: 17114424
PLoS One. 2013 Nov 05;8(11):e77773
pubmed: 24223725
Am J Gastroenterol. 2004 Dec;99(12):2393-404
pubmed: 15571588
Cell Signal. 2005 Sep;17(9):1111-24
pubmed: 15993752
Int Immunol. 2001 Feb;13(2):241-8
pubmed: 11157857
Lancet. 2002 May 11;359(9318):1661-5
pubmed: 12020527
Innate Immun. 2010 Jun;16(3):160-7
pubmed: 20418254
Cancer Res. 2000 Mar 15;60(6):1704-10
pubmed: 10749143
Immunity. 2005 Sep;23(3):319-29
pubmed: 16169504
Obesity (Silver Spring). 2013 Apr;21(4):731-6
pubmed: 23712976
J Biol Chem. 1997 May 23;272(21):13743-9
pubmed: 9153228
Therap Adv Gastroenterol. 2009 Jul;2(4):245-51
pubmed: 21180547
Gut. 2009 Mar;58(3):388-95
pubmed: 18824555
Gastroenterology. 2007 Nov;133(5):1499-509
pubmed: 17983803
Cell. 2013 Sep 26;155(1):57-69
pubmed: 24035192
Transl Res. 2012 Apr;159(4):313-25
pubmed: 22424434
J Crohns Colitis. 2018 Jan 5;12(1):39-47
pubmed: 28961726
Med Wieku Rozwoj. 2001 Apr-Jun;5(2 Suppl 1):18-118
pubmed: 11675534
Clin Transl Gastroenterol. 2012 Feb 16;3:e10
pubmed: 23238132
Gastroenterology. 2002 Sep;123(3):679-88
pubmed: 12198692
Inflamm Bowel Dis. 2013 Apr;19(5):1099-105
pubmed: 23493074
Ann Hum Genet. 2011 Sep;75(5):559-68
pubmed: 21790524
Tissue Antigens. 2003 Dec;62(6):527-35
pubmed: 14617036
J Infect Dis. 2009 Mar 1;199(5):661-5
pubmed: 19199539
Am J Gastroenterol. 2011 Apr;106(4):699-712
pubmed: 21343918
Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10794-9
pubmed: 10485905
Genes Immun. 2004 Nov;5(7):530-9
pubmed: 15505619
Nat Genet. 1997 Sep;17(1):32-9
pubmed: 9288095
Gastroenterol Hepatol (N Y). 2011 Oct;7(10):652-9
pubmed: 22298958
Lancet. 2018 Dec 23;390(10114):2769-2778
pubmed: 29050646
J Immunol. 2000 Aug 15;165(4):1762-70
pubmed: 10925253
Inflamm Bowel Dis. 2009 Jun;15(6):918-25
pubmed: 19340882
Nat Genet. 2015 Feb;47(2):172-9
pubmed: 25559196
Cell Prolif. 2019 Nov;52(6):e12673
pubmed: 31418947
J Immunol. 2005 Feb 1;174(3):1532-8
pubmed: 15661913